ZLAB News and Press, Zai Lab Limited

2026-06-18 07:51:24 ET More on NovoCure NovoCure: Pancreatic Launch Looks Promising, But I'm Not A Believer Yet NovoCure Limited (NVCR) Q1 2026 Earnings Call Transcript NovoCure Limited 2026 Q1 - Results - Earnings Call Presentation Novocure outlines $690M-$7...

- European Medicines Agency’s Committee for Orphan Medicinal Products recognized zoci’s preliminary clinical data as suggestive of a clinically relevant advantage over currently authorized therapies in relapsed or refractory extensive-stage small cell lung cancer (SCLC) - SC...

2026-06-09 07:30:31 ET More on Pfizer, Zai Lab Pfizer Inc. (PFE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript Pfizer Inc. (PFE) Presents at Jefferies Global Healthcare Conference 2026 Transcript Pfizer: Reduced TrumpRx/Patent Ris...

- TIVDAK is the first antibody-drug conjugate (ADC) approved for the treatment of previously treated recurrent or metastatic cervical cancer in China - TIVDAK demonstrated a statistically significant overall survival benefit in the global Phase 3 innovaTV 301 clinical trial, including in ...

2026-06-01 15:02:17 ET Image source: The Motley Fool. Thursday, May 7, 2026 at 9 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-26 10:10:32 ET TransMedics: Despite Earnings Miss, Growth Story Remains Intact Relay Therapeutics, Inc. (RLAY) Presents at ISSVA World Congress 2026: The Latest in Vascular Anomalies - Slideshow Relay Therapeutics: Encouraging Data, Competitive Risks (Downgrade) ...

2026-05-22 02:45:48 ET Biotech firm Zai Lab ( ZLAB ) announced that President and COO Josh Smiley is leaving the company immediately as part of a leadership shake-up to improve efficiency.... Read the full article on Seeking Alpha For further details see: Zai...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced changes to its senior leadership team aimed at strengthening operational performance and efficiency. As part of these changes, the Board has made the decision that Josh Smiley, President and COO, will no longer be with the Company, effect...

2026-05-13 09:57:20 ET Zai Lab Overview My 2023 Buy rating on Zai Lab Limited ( ZLAB ) was anchored to its ability to in-license blockbuster drugs and squeeze out every drop of profit in the Greater China market. But this didn't happen. National Reimbursement Drug List ((NRD...

2026-05-11 07:26:07 ET Read the full article on Seeking Alpha For further details see: Zai Lab wins FDA fast track status for cancer drug zocilurtatug pelitecan